Company intelligence / Profile preview

Tribeca Productions

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Tribeca Bio is an early-stage biotechnology company focused on the development of next-generation RNA therapeutics. The company utilizes a proprietary non-viral delivery platform designed to overcome the significant challenges associated with traditional RNA delivery, such as tissue specificity, immunogenicity, and payload stability. By enabling the targeted delivery of RNA payloads to specific cells and tissues, Tribeca Bio aims to expand the therapeutic potential of RNA-based medicines. The company's current pipeline is primarily directed toward addressing unmet needs in oncology and rare genetic disorders.

Therapeutic areas: OncologyRare Diseases
Modalities: RNA therapyLipid nanoparticle delivery therapyNanoparticle
Industry: Biotech

Beyond the preview

Go deeper on Tribeca Productions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tribeca Productions.

Explore the full profile